{
  "quoteSummary": {
    "result": [
      {
        "defaultKeyStatistics": {
          "maxAge": 1,
          "priceHint": {
            "raw": 2,
            "fmt": "2",
            "longFmt": "2"
          },
          "enterpriseValue": {
            "raw": 18056720384,
            "fmt": "18.06B",
            "longFmt": "18,056,720,384"
          },
          "forwardPE": {},
          "profitMargins": {
            "raw": -0.118319996,
            "fmt": "-11.83%"
          },
          "floatShares": {
            "raw": 3956186,
            "fmt": "3.96M",
            "longFmt": "3,956,186"
          },
          "sharesOutstanding": {
            "raw": 61250700,
            "fmt": "61.25M",
            "longFmt": "61,250,700"
          },
          "sharesShort": {},
          "sharesShortPriorMonth": {},
          "heldPercentInsiders": {},
          "heldPercentInstitutions": {},
          "shortRatio": {},
          "shortPercentOfFloat": {},
          "beta": {
            "raw": 0.995133,
            "fmt": "1"
          },
          "morningStarOverallRating": {},
          "morningStarRiskRating": {},
          "category": null,
          "bookValue": {
            "raw": 62.218,
            "fmt": "62.22"
          },
          "priceToBook": {
            "raw": 4.361278,
            "fmt": "4.36"
          },
          "annualReportExpenseRatio": {},
          "ytdReturn": {},
          "beta3Year": {},
          "totalAssets": {},
          "yield": {},
          "fundFamily": null,
          "fundInceptionDate": {},
          "legalType": null,
          "threeYearAverageReturn": {},
          "fiveYearAverageReturn": {},
          "priceToSalesTrailing12Months": {},
          "lastFiscalYearEnd": {
            "raw": 1490918400,
            "fmt": "2017-03-31"
          },
          "nextFiscalYearEnd": {
            "raw": 1553990400,
            "fmt": "2019-03-31"
          },
          "mostRecentQuarter": {
            "raw": 1506729600,
            "fmt": "2017-09-30"
          },
          "earningsQuarterlyGrowth": {},
          "revenueQuarterlyGrowth": {},
          "netIncomeToCommon": {
            "raw": -644600000,
            "fmt": "-644.6M",
            "longFmt": "-644,600,000"
          },
          "trailingEps": {
            "raw": -10.524,
            "fmt": "-10.52"
          },
          "forwardEps": {},
          "pegRatio": {},
          "lastSplitFactor": "10/1",
          "lastSplitDate": {
            "raw": 1044230400,
            "fmt": "2003-02-03"
          },
          "enterpriseToRevenue": {
            "raw": 3.314,
            "fmt": "3.31"
          },
          "enterpriseToEbitda": {
            "raw": 15.747,
            "fmt": "15.75"
          },
          "52WeekChange": {
            "raw": "Infinity",
            "fmt": "\u00e2\u02c6\u017e%"
          },
          "SandP52WeekChange": {
            "raw": 0.12668931,
            "fmt": "12.67%"
          },
          "lastDividendValue": {},
          "lastCapGain": {},
          "annualHoldingsTurnover": {}
        },
        "earnings": {
          "maxAge": 86400,
          "earningsChart": {
            "quarterly": []
          },
          "financialsChart": {
            "yearly": [
              {
                "date": 2014,
                "revenue": {
                  "raw": 5099900000,
                  "fmt": "5.1B",
                  "longFmt": "5,099,900,000"
                },
                "earnings": {
                  "raw": -1121300000,
                  "fmt": "-1.12B",
                  "longFmt": "-1,121,300,000"
                }
              },
              {
                "date": 2015,
                "revenue": {
                  "raw": 6871900000,
                  "fmt": "6.87B",
                  "longFmt": "6,871,900,000"
                },
                "earnings": {
                  "raw": -1065000000,
                  "fmt": "-1.06B",
                  "longFmt": "-1,065,000,000"
                }
              },
              {
                "date": 2016,
                "revenue": {
                  "raw": 6530800000,
                  "fmt": "6.53B",
                  "longFmt": "6,530,800,000"
                },
                "earnings": {
                  "raw": -182900000,
                  "fmt": "-182.9M",
                  "longFmt": "-182,900,000"
                }
              },
              {
                "date": 2017,
                "revenue": {
                  "raw": 5448000000,
                  "fmt": "5.45B",
                  "longFmt": "5,448,000,000"
                },
                "earnings": {
                  "raw": -644600000,
                  "fmt": "-644.6M",
                  "longFmt": "-644,600,000"
                }
              }
            ],
            "quarterly": [
              {
                "date": "3Q2017",
                "revenue": {
                  "raw": 0,
                  "fmt": null,
                  "longFmt": "0"
                },
                "earnings": {
                  "raw": 0,
                  "fmt": null,
                  "longFmt": "0"
                }
              }
            ]
          },
          "financialCurrency": "INR"
        },
        "summaryProfile": {
          "address1": "B-1 Extn./G-3",
          "address2": "Mohan Co-operative Industrial Estate Mathura Road",
          "city": "New Delhi",
          "zip": "110044",
          "country": "India",
          "phone": "91 11 4167 9000",
          "fax": "91 11 4167 9070",
          "website": "http://www.panacea-biotec.com",
          "industry": "Biotechnology",
          "sector": "Healthcare",
          "longBusinessSummary": "Panacea Biotec Limited, a health management company, researches, develops, manufactures, and markets pharmaceutical formulations, vaccines, and biopharmaceuticals in India. The company operates through Vaccines, Formulations, and Research & Development segments. Its product portfolio includes prescription products in various therapeutic areas, including diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The company also acquires, constructs, and develops housing and commercial real estate projects. It exports its products to approximately 30 countries. Panacea Biotec Limited has strategic alliance with Apotex Inc. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India.",
          "companyOfficers": [],
          "maxAge": 86400
        },
        "financialData": {
          "maxAge": 86400,
          "currentPrice": {
            "raw": 271.35,
            "fmt": "271.35"
          },
          "targetHighPrice": {
            "raw": 69.0,
            "fmt": "69.00"
          },
          "targetLowPrice": {
            "raw": 69.0,
            "fmt": "69.00"
          },
          "targetMeanPrice": {
            "raw": 69.0,
            "fmt": "69.00"
          },
          "targetMedianPrice": {
            "raw": 69.0,
            "fmt": "69.00"
          },
          "recommendationMean": {},
          "recommendationKey": "none",
          "numberOfAnalystOpinions": {
            "raw": 1,
            "fmt": "1",
            "longFmt": "1"
          },
          "totalCash": {},
          "totalCashPerShare": {},
          "ebitda": {
            "raw": 1146700032,
            "fmt": "1.15B",
            "longFmt": "1,146,700,032"
          },
          "totalDebt": {},
          "quickRatio": {
            "raw": 0.341,
            "fmt": "0.34"
          },
          "currentRatio": {
            "raw": 1.019,
            "fmt": "1.02"
          },
          "totalRevenue": {
            "raw": 5448000000,
            "fmt": "5.45B",
            "longFmt": "5,448,000,000"
          },
          "debtToEquity": {},
          "revenuePerShare": {
            "raw": 88.946,
            "fmt": "88.95"
          },
          "returnOnAssets": {
            "raw": 0.01878,
            "fmt": "1.88%"
          },
          "returnOnEquity": {
            "raw": -0.15474,
            "fmt": "-15.47%"
          },
          "grossProfits": {
            "raw": 3697700000,
            "fmt": "3.7B",
            "longFmt": "3,697,700,000"
          },
          "freeCashflow": {
            "raw": -164450000,
            "fmt": "-164.45M",
            "longFmt": "-164,450,000"
          },
          "operatingCashflow": {
            "raw": 1146599936,
            "fmt": "1.15B",
            "longFmt": "1,146,599,936"
          },
          "earningsGrowth": {},
          "revenueGrowth": {},
          "grossMargins": {
            "raw": 0.67873,
            "fmt": "67.87%"
          },
          "ebitdaMargins": {
            "raw": 0.21048,
            "fmt": "21.05%"
          },
          "operatingMargins": {
            "raw": 0.10248,
            "fmt": "10.25%"
          },
          "profitMargins": {
            "raw": -0.118319996,
            "fmt": "-11.83%"
          },
          "financialCurrency": "INR"
        }
      }
    ],
    "error": null
  }
}